TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.850
-0.010 (-0.54%)
Aug 4, 2025, 4:00 PM - Market closed
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $73.18 million as of August 4, 2025. Its market cap has decreased by -35.90% in one year.
Market Cap
73.18M
Enterprise Value
75.05M
1-Year Change
-35.90%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $73.18M, a decrease of -50.20%. That is a compound annual growth rate of -11.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 73.57M | -38.15% |
| Dec 31, 2024 | 118.95M | -26.62% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | 217.06M | 46.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |